Antiplatelet agents

Name
Antiplatelet agents
Accession Number
DBCAT000149
Description

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Drugs
DrugDrug Description
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamineNot Available
AbciximabA monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention.
Acetylsalicylic acidA salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events.
AjoeneNot Annotated
AloxistatinNot Annotated
AnagrelideA platelet-reducing agent used to treat thrombocythemia, and its related complications, secondary to myeloproliferative neoplasms.
AndrographolideInvestigated for use/treatment in ulcerative colitis.
ApafantApafant is a small molecule drug. The usage of the INN stem '-pafant' in the name indicates that Apafant is a platelet-activating factor antagonist. Apafant has a monoisotopic molecular weight...
AtaprostAtaprost is a small molecule drug. Ataprost has a monoisotopic molecular weight of 348.23 Da.
BeraprostFor the treatment of pulmonary hypertension.
Bisindolylmaleimide VIIINot Available
BuflomedilNot Annotated
ButylphthalideButylphthalide has been used in trials studying the prevention of Restenosis.
CangrelorA P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST).
CaplacizumabA von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP).
CilostamideCilostamide is a small molecule drug. Cilostamide has a monoisotopic molecular weight of 342.19 Da.
CilostazolAn antiplatelet agent and vasodilator used for the symptomatic relief of intermittent claudication.
ClopidogrelAn antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease.
CloricromenNot Annotated
DaltrobanDaltroban is a small molecule drug. Daltroban has a monoisotopic molecular weight of 353.05 Da.
DazmegrelDazmegrel is a small molecule drug. Dazmegrel has a monoisotopic molecular weight of 283.13 Da.
DefibrotideA mixture of single-stranded oligonucleotides used in the treatment of severe hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation.
DipyridamoleA phosphodiesterase inhibitor used to prevent postoperative thromboembolic events.
EfegatranEfegatran is a small molecule drug. Efegatran has a monoisotopic molecular weight of 416.25 Da.
EmoxypineEmoxypine is under investigation in clinical trial NCT06221826 (MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure).
Enfenamic acidEnfenamic acid is a small molecule drug. Enfenamic acid has a monoisotopic molecular weight of 241.11 Da.
EpoprostenolA vasodilator and platelet aggregation inhibitor used for the management of primary pulmonary hypertension and pulmonary hypertension in patients with heart failure.
EptifibatideA peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention.
ForopafantForopafant is a small molecule drug. The usage of the INN stem '-pafant' in the name indicates that Foropafant is a platelet-activating factor antagonist. Foropafant has a monoisotopic molecular weight...
HydroxytyrosolHydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
IbudilastFor the treatment of multiple sclerosis, asthma, and cerebrovascular disease.
Icosapent ethylAn ethyl ester of eicosapentaenoic acid (EPA) that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia.
IfetrobanIfetroban has been used in trials studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and Scleroderma, Diffuse, among others.
IloprostA synthetic prostacyclin analog used to treat pulmonary arterial hypertension (PAH) and frostbites.
IndobufenA reversible platelet aggregation inhibitor used to prevent coronary and peripheral artery occlusion.
KetanserinKetanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.
LamifibanLamifiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). Lamifiban has...
LigustrazineLigustrazine is under investigation in clinical trial NCT05942352 (Clinical Study of Ligustrazine in Treating Alcohol Addiction).
LinsidomineNot Annotated
Maritime pine extractA plant extract in nutritional supplements for healthy hair, skin, and nails.
NaftopidilNaftopidil has been investigated for the treatment of Disorder of Urinary Stent.
NimesulideA cyclooxygenase 2 inhibitor used to treat acute pain and primary dysmenorrhea.
NitroaspirinNitroaspirin has been investigated for the treatment of Intermittent Claudication.
PentoxifyllineA methylxanthine derivative used to treat intermittent claudication caused by chronic occlusive arterial disease of the limbs.
PicotamideA platelet aggregation inhibitor indicated in the treatment of myocardial infarction, thrombosis, cerebrovascular disorders, pulmonary emboli, and atherosclerosis.
PiroximonePiroximone is a small molecule drug. Piroximone has a monoisotopic molecular weight of 217.09 Da.
PlafibridePlafibride is a small molecule drug. Plafibride has a monoisotopic molecular weight of 355.13 Da.
PrasugrelA P2Y12 platelet inhibitor used to reduce risk of thrombotic cardiovascular events in unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and in patients with STEMI when managed with either primary or delayed PCI.
RamatrobanRamatroban has been used in trials studying the treatment of Asthma.
RelcovaptanNot Annotated
ResveratrolBeing investigated for the treatment of Herpes labialis infections (cold sores).
RidogrelUsed as an adjunctive therapy to induce thrombolysis in patients suffering acute myocardial infarction.
Rosmarinic acidNot Annotated
S-NitrosoglutathioneNot Annotated
SarpogrelateSarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic.
SatigrelSatigrel is a small molecule drug. Satigrel has a monoisotopic molecular weight of 337.13 Da.
SibrafibanSibrafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Sibrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). Sibrafiban has...
SKF-96365 free baseSKF-96365 is a receptor-mediated calcium entry (RMCE) inhibitor structurally different from other calcium antagonists.
SulfinpyrazoneA platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout .
SulotrobanSulotroban is a small molecule drug. Sulotroban has a monoisotopic molecular weight of 335.08 Da.
TesmilifeneIntended for the treatment of various forms of cancer.
TicagrelorA P2Y12 platelet inhibitor used in patients with a history of myocardial infarction or with acute coronary syndrome (ACS) to prevent future myocardial infarction, stroke and cardiovascular death.
TiclopidineA platelet aggregation inhibitor used in the prevention of conditions associated with thrombi, such as stroke and transient ischemic attacks (TIA).
TirofibanA platelet aggregation inhibitor used to prevent thrombotic events in non-ST elevated acute coronary syndrome.
TranilastFor the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
TrapidilUsed in the treatment of chronic stable angina .
TriflusalA medication related to acetylsalicylic acid with antithrombotic effects used in the treatment of thromboembolic diseases.
VapiprostVapiprost is a small molecule drug. Vapiprost has a monoisotopic molecular weight of 477.29 Da.
VicagrelVicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel).
VorapaxarA platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD).
XemilofibanXemilofiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Xemilofiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). Xemilofiban has...
Drugs & Drug Targets
DrugTargetType
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamineRhodopsintarget
AbciximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
AbciximabIntegrin beta-3target
AbciximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
AbciximabIntegrin alpha-IIbtarget
AbciximabVitronectintarget
Acetylsalicylic acidG1/S-specific cyclin-D1target
Acetylsalicylic acidHuman Cyclooxygenasestarget
Acetylsalicylic acid3-hydroxy-3-methylglutaryl-coenzyme A reductasetarget
Acetylsalicylic acidSialidase-1target
Acetylsalicylic acidOrganic anion transporter 3transporter
Acetylsalicylic acidArylamine N-acetyltransferase 2enzyme
Acetylsalicylic acidUDP-glucuronosyltransferase 1A6enzyme
Acetylsalicylic acidCyclin Atarget
Acetylsalicylic acidDNA sliding clamp PCNAtarget
Acetylsalicylic acidMyc proto-oncogene proteintarget
Acetylsalicylic acidCaspase-3target
Acetylsalicylic acidCaspase-1target
Acetylsalicylic acidTumor necrosis factor-inducible gene 6 proteintarget
Acetylsalicylic acidNF-kappa-B inhibitor alphatarget
Acetylsalicylic acidRibosomal protein S6 kinase alpha-3target
Acetylsalicylic acidEndoplasmic reticulum chaperone BiPtarget
Acetylsalicylic acidCellular tumor antigen p53target
Acetylsalicylic acidEndothelin-1 receptortarget
Acetylsalicylic acid5'-AMP-activated protein kinasetarget
Acetylsalicylic acidCytochrome P450 2C9enzyme
Acetylsalicylic acidCytochrome P450 2C19enzyme
Acetylsalicylic acidATP-dependent translocase ABCB1transporter
Acetylsalicylic acidSolute carrier family 22 member 6transporter
Acetylsalicylic acidAldo-keto reductase family 1 member C1target
Acetylsalicylic acidProstaglandin G/H synthase 2target
Acetylsalicylic acidProstaglandin G/H synthase 1target
AjoeneIntegrin beta-3target
AjoeneIntegrin alpha-IIbtarget
AloxistatinCalpain-2 catalytic subunittarget
AloxistatinCathepsin Gtarget
AnagrelideCytochrome P450 1A2enzyme
AnagrelidePhosphodiesterase 3target
AnagrelidecGMP-inhibited 3',5'-cyclic phosphodiesterase 3Atarget
AndrographolideInterleukin-1 betatarget
AndrographolideTumor necrosis factortarget
AndrographolideInterleukin-6target
AndrographolideNuclear factor NF-kappa-B p100 subunittarget
AndrographolideNuclear factor NF-kappa-B p105 subunittarget
ApafantPlatelet-activating factor receptortarget
AtaprostProstacyclin receptortarget
BeraprostCytochrome P450 2C8enzyme
BeraprostProstacyclin receptortarget
Bisindolylmaleimide VIIIMyotonin-protein kinasetarget
Bisindolylmaleimide VIII3-phosphoinositide-dependent protein kinase 1target
BuflomedilAlpha-1B adrenergic receptortarget
BuflomedilAlpha-1A adrenergic receptortarget
BuflomedilAlpha-2 adrenergic receptorstarget
ButylphthalideKelch-like ECH-associated protein 1target
CangrelorP2Y purinoceptor 12target
Caplacizumabvon Willebrand factortarget
CilostamidecGMP-inhibited 3',5'-cyclic phosphodiesterase 3Btarget
CilostamidecGMP-inhibited 3',5'-cyclic phosphodiesterase 3Atarget
CilostamidePhosphodiesterase 3target
CilostazolCytochrome P450 1A2enzyme
CilostazolCytochrome P450 2D6enzyme
CilostazolCytochrome P450 3A7enzyme
CilostazolCytochrome P450 3A5enzyme
CilostazolCytochrome P450 3A4enzyme
CilostazolCytochrome P450 2C19enzyme
CilostazolcGMP-inhibited 3',5'-cyclic phosphodiesterase 3Atarget
ClopidogrelCytochrome P450 3A4enzyme
ClopidogrelP2Y purinoceptor 12target
ClopidogrelCytochrome P450 2C19enzyme
ClopidogrelCytochrome P450 2B6enzyme
ClopidogrelCytochrome P450 3A5enzyme
ClopidogrelAlbumincarrier
ClopidogrelSolute carrier family 22 member 2transporter
ClopidogrelSolute carrier family 22 member 1transporter
ClopidogrelCytochrome P450 2C9enzyme
ClopidogrelATP-dependent translocase ABCB1transporter
ClopidogrelLiver carboxylesterase 1enzyme
ClopidogrelCytochrome P450 2C8enzyme
ClopidogrelCytochrome P450 1A2enzyme
CloricromenPhospholipase A2target
DaltrobanThromboxane A2 receptortarget
DazmegrelThromboxane-A synthasetarget
DefibrotideProthrombintarget
DefibrotidePlasminogentarget
DefibrotideAdenosine receptor A2btarget
DefibrotideAdenosine receptor A2atarget
DefibrotideAdenosine receptor A1target
DipyridamoleAdenosine deaminasetarget
Dipyridamole3',5'-cyclic-AMP phosphodiesterase 4Atarget
DipyridamolecGMP-specific 3',5'-cyclic phosphodiesterasetarget
DipyridamolecAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10Atarget
DipyridamoleATP-binding cassette sub-family C member 4transporter
DipyridamoleATP-binding cassette sub-family C member 5transporter
DipyridamoleATP-dependent translocase ABCB1transporter
DipyridamoleCalcipressin-1target
DipyridamoleAlpha-1-acid glycoprotein 1target
DipyridamoleSolute carrier organic anion transporter family member 1B1transporter
DipyridamoleSolute carrier organic anion transporter family member 1B3transporter
DipyridamoleSolute carrier organic anion transporter family member 2B1transporter
DipyridamoleBile salt export pumptransporter
DipyridamoleEquilibrative nucleoside transporter 1target
DipyridamoleCyclic nucleotide phosphodiesterasetarget
EfegatranProthrombintarget
EmoxypineMuscarinic acetylcholine receptortarget
EmoxypineNeuronal Acetylcholine (nACh) Receptor Subunitstarget
EmoxypineTranslocator proteintarget
EmoxypineGABA(A) Receptor Benzodiazepine Binding Sitetarget
EmoxypineGABA(A) Receptortarget
Enfenamic acidFructose-1,6-bisphosphatase 1target
Enfenamic acidPhosphoenolpyruvate Carboxykinasestarget
Enfenamic acidPyruvate carboxylase, mitochondrialtarget
EpoprostenolProstacyclin receptortarget
EpoprostenolProstacyclin synthasetarget
EpoprostenolP2Y purinoceptor 12target
EptifibatideIntegrin beta-3target
EptifibatideVoltage-dependent N-type calcium channeltarget
EptifibatideIntegrin alpha-IIbtarget
ForopafantPlatelet-activating factor receptortarget
HydroxytyrosolNuclear factor erythroid 2-related factor 2target
HydroxytyrosolBeta-glucosidase Aenzyme
HydroxytyrosolCytochrome P450 2A6enzyme
HydroxytyrosolCytochrome P450 2D6enzyme
Ibudilast3',5'-cyclic-AMP phosphodiesterase 4Ctarget
Ibudilast3',5'-cyclic-AMP phosphodiesterase 4Btarget
Ibudilast3',5'-cyclic-AMP phosphodiesterase 4Dtarget
IbudilastPhosphodiesterase 4target
IbudilastcGMP-inhibited 3',5'-cyclic phosphodiesterase 3Atarget
Ibudilast3',5'-cyclic-AMP phosphodiesterase 4Atarget
IbudilastcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10Atarget
IbudilastcGMP-specific 3',5'-cyclic phosphodiesterasetarget
Icosapent ethylProstaglandin G/H synthase 1target
IfetrobanThromboxane A2 receptortarget
IloprostProstacyclin receptortarget
IloprostProstaglandin D2 receptor 2target
IloprostProstaglandin E2 receptor EP2 subtypetarget
IloprostAlbumincarrier
IloprostProstaglandin E2 receptor EP1 subtypetarget
Iloprost3',5'-cyclic-AMP phosphodiesterase 4Dtarget
Iloprost3',5'-cyclic-AMP phosphodiesterase 4Ctarget
Iloprost3',5'-cyclic-AMP phosphodiesterase 4Btarget
IloprostSolute carrier organic anion transporter family member 3A1transporter
IloprostSolute carrier organic anion transporter family member 2A1transporter
IloprostSolute carrier organic anion transporter family member 2B1transporter
Iloprost3',5'-cyclic-AMP phosphodiesterase 4Atarget
IloprostTissue-type plasminogen activatortarget
IndobufenProstaglandin G/H synthase 1target
Ketanserin5-hydroxytryptamine receptor 2Atarget
LamifibanIntegrin beta-3target
LamifibanIntegrin alpha-IIbtarget
LigustrazineCyclic nucleotide phosphodiesterasetarget
LigustrazinePeroxisome proliferator-activated receptor gammatarget
LigustrazineNuclear receptor subfamily 1 group I member 2target
Maritime pine extractAlpha-glucosidasetarget
Maritime pine extractTranscription factor Juntarget
NaftopidilCytochrome P450 3A4enzyme
NaftopidilAlpha-1A adrenergic receptortarget
NaftopidilAlpha-1D adrenergic receptortarget
NimesulideTumor necrosis factor ligand superfamily member 10target
NimesulideCytochrome P450 3A4enzyme
NimesulideLactotransferrintarget
NimesulideGroup IIE secretory phospholipase A2target
NimesulideProstaglandin G/H synthase 2target
NitroaspirinProstaglandin G/H synthase 2target
NitroaspirinProstaglandin G/H synthase 1target
Pentoxifylline5'-nucleotidasetarget
PentoxifyllineAdenosine receptor A1target
PentoxifyllineAdenosine receptor A2atarget
PentoxifyllineCytochrome P450 1A2enzyme
PentoxifyllinePhosphodiesterase enzymestarget
PentoxifyllineTumor necrosis factortarget
PentoxifyllineCyclic nucleotide phosphodiesterasetarget
PicotamideThromboxane A2 receptortarget
PicotamideThromboxane-A synthasetarget
PiroximonePhosphodiesterase 3target
PiroximoneCyclic nucleotide phosphodiesterasetarget
PrasugrelAlbumincarrier
PrasugrelCytochrome P450 2C19enzyme
PrasugrelCytochrome P450 2C9enzyme
PrasugrelCytochrome P450 2B6enzyme
PrasugrelCytochrome P450 3A4enzyme
PrasugrelCocaine esteraseenzyme
PrasugrelP2Y purinoceptor 12target
RamatrobanProstaglandin D2 receptor 2target
RamatrobanThromboxane A2 receptortarget
RelcovaptanVasopressin V1a receptortarget
RelcovaptanOxytocin receptortarget
ResveratrolProstaglandin G/H synthase 2target
ResveratrolNAD-dependent protein deacetylase sirtuin-1target
ResveratrolCytochrome P450 1A1enzyme
ResveratrolCytochrome P450 3A4enzyme
ResveratrolCytochrome P450 1A2enzyme
ResveratrolCytochrome P450 1B1enzyme
ResveratrolPolyunsaturated fatty acid lipoxygenase ALOX15target
ResveratrolPolyunsaturated fatty acid 5-lipoxygenasetarget
ResveratrolAryl hydrocarbon receptortarget
ResveratrolPhosphatidylinositol 4-kinase type 2-betatarget
ResveratrolIntegrin alpha-5target
ResveratrolIntegrin beta-3target
ResveratrolAlbumincarrier
ResveratrolAmyloid-beta precursor proteintarget
ResveratrolAlpha-synucleintarget
ResveratrolEstrogen receptortarget
ResveratrolMelatonin receptor type 1Atarget
ResveratrolMelatonin receptor type 1Btarget
ResveratrolC-type lectin domain family 14 member Atarget
ResveratrolNuclear receptor subfamily 1 group I member 2target
ResveratrolNuclear receptor subfamily 1 group I member 3target
ResveratrolSolute carrier family 2, facilitated glucose transporter member 1target
ResveratrolCarbonyl reductase [NADPH] 1target
ResveratrolPeroxisome proliferator-activated receptor alphatarget
ResveratrolPeroxisome proliferator-activated receptor gammatarget
ResveratrolRAC-alpha serine/threonine-protein kinasetarget
ResveratrolFar upstream element-binding protein 2target
ResveratrolTyrosine--tRNA ligase, cytoplasmictarget
ResveratrolCytochrome P450 2D6enzyme
ResveratrolCytochrome P450 2B6enzyme
ResveratrolCytochrome P450 2C19enzyme
ResveratrolCytochrome P450 2C9enzyme
ResveratrolCasein kinase II subunit alphatarget
ResveratrolProstaglandin G/H synthase 1target
ResveratrolRibosyldihydronicotinamide dehydrogenase [quinone]target
ResveratrolTransthyretincarrier
RidogrelThromboxane A2 receptortarget
RidogrelThromboxane-A synthasetarget
Rosmarinic acidInduced myeloid leukemia cell differentiation protein Mcl-1target
Rosmarinic acidTyrosinasetarget
S-NitrosoglutathioneV-ATPase Subunitstarget
S-NitrosoglutathioneThioredoxinenzyme
S-NitrosoglutathioneThioredoxin reductase 1, cytoplasmicenzyme
S-NitrosoglutathioneGlutathione reductase, mitochondrialenzyme
S-NitrosoglutathioneGlutathione hydrolase 1 proenzymeenzyme
S-NitrosoglutathioneAlcohol dehydrogenase class-3enzyme
Sarpogrelate5-hydroxytryptamine receptor 2Ctarget
Sarpogrelate5-hydroxytryptamine receptor 2Atarget
SatigrelThromboxane-A synthasetarget
SibrafibanIntegrin beta-3target
SibrafibanIntegrin alpha-IIbtarget
SKF-96365 free baseVoltage-gated inwardly rectifying potassium channel KCNH2target
SKF-96365 free basePotassium voltage-gated channel subfamily KQT member 1target
SKF-96365 free baseInward rectifier potassium channel 2target
SKF-96365 free baseShort transient receptor potential channel 1target
SKF-96365 free baseShort transient receptor potential channel 6target
SKF-96365 free baseTransient receptor potential cation channel subfamily V member 2target
SKF-96365 free baseTransient receptor potential cation channel subfamily M member 8target
SKF-96365 free baseCalcium release-activated calcium channel protein 1target
SKF-96365 free baseStromal interaction molecule 1target
SulfinpyrazoneNuclear receptor subfamily 1 group I member 2target
SulfinpyrazoneMultidrug resistance-associated protein 1transporter
SulfinpyrazoneBile salt export pumptransporter
SulfinpyrazoneCytochrome P450 3A4enzyme
SulfinpyrazoneSolute carrier family 22 member 12target
SulfinpyrazoneCytochrome P450 2C8enzyme
SulfinpyrazoneATP-binding cassette sub-family C member 2transporter
SulfinpyrazoneCytochrome P450 2B6enzyme
SulfinpyrazoneATP-binding cassette sub-family C member 6transporter
SulfinpyrazoneATP-binding cassette sub-family C member 5transporter
SulfinpyrazoneATP-binding cassette sub-family C member 4transporter
SulfinpyrazoneATP-binding cassette sub-family C member 3transporter
SulfinpyrazoneCytochrome P450 2C9enzyme
SulfinpyrazoneFatty acid-binding protein, intestinalcarrier
SulfinpyrazoneATP-binding cassette sub-family C member 2target
SulfinpyrazoneMultidrug resistance-associated protein 1target
SulotrobanThromboxane A2 receptortarget
TesmilifeneCytochrome P450 1A1enzyme
TesmilifeneCytochrome P450 2D6enzyme
TesmilifeneCytochrome P450 3A4enzyme
TesmilifeneHistamine H1 receptortarget
TesmilifeneATP-dependent translocase ABCB1target
TicagrelorCytochrome P450 2B6enzyme
TicagrelorCytochrome P450 3A5enzyme
TicagrelorAlbumincarrier
TicagrelorCytochrome P450 2C9enzyme
TicagrelorATP-dependent translocase ABCB1transporter
TicagrelorP2Y purinoceptor 12target
TicagrelorCytochrome P450 3A4enzyme
TiclopidineMyeloperoxidaseenzyme
TiclopidineCytochrome P450 1A2enzyme
TiclopidineCytochrome P450 2C8enzyme
TiclopidineCytochrome P450 2E1enzyme
TiclopidinePlatelet-activating factor receptortarget
TiclopidineP2Y purinoceptor 12target
TiclopidineCytochrome P450 2C19enzyme
TiclopidineCytochrome P450 2B6enzyme
TiclopidineCytochrome P450 2C9enzyme
TiclopidineCytochrome P450 2D6enzyme
TirofibanIntegrin alpha-IIbtarget
TirofibanIntegrin beta-3target
TranilastHistamine H1 receptortarget
TranilastHematopoietic prostaglandin D synthasetarget
TranilastCytochrome P450 3A4enzyme
TranilastCytochrome P450 2C9enzyme
TranilastSteryl-sulfatasetarget
TrapidilFibroblast growth factor receptor 3target
TrapidilCyclic nucleotide phosphodiesterasetarget
TrapidilPlatelet-derived growth factor receptor betatarget
TriflusalNitric oxide synthase, inducibletarget
TriflusalNuclear factor NF-kappa-B p105 subunittarget
TriflusalProstaglandin G/H synthase 1target
TriflusalAlbumincarrier
TriflusalcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10Atarget
VapiprostThromboxane A2 receptortarget
VicagrelP2Y purinoceptor 12target
VicagrelCocaine esteraseenzyme
VicagrelArylacetamide deacetylaseenzyme
VicagrelIntestinal-type alkaline phosphataseenzyme
VicagrelLiver carboxylesterase 1enzyme
VicagrelCytochrome P450 2C19enzyme
VorapaxarCytochrome P450 2J2enzyme
VorapaxarProteinase-activated receptor 1target
VorapaxarCytochrome P450 3A4enzyme
VorapaxarATP-dependent translocase ABCB1transporter
XemilofibanIntegrin beta-3target
XemilofibanIntegrin alpha-IIbtarget